Developing efficient methods to create new drug compounds
Catalytic and Stereoselective C-C-Heteroatom Bond Forming Reactions
This study is working on finding quicker and cheaper ways to create new versions of medicines by changing certain parts of natural compounds, which could help make important drugs more accessible for everyone.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Florida NIH-funded |
| Lab location | 1 site (Gainesville, United States) |
| Project ID | NIH-10873720 on NIH RePORTER |
What this research studies
This research focuses on creating new analogues of natural products and pharmaceuticals in a more efficient and cost-effective way. By developing catalytic processes, the team aims to transform common chemical bonds in bioactive molecules into useful drug derivatives. These new compounds will be designed with special tags that allow for further study and development, potentially speeding up the drug discovery process. The goal is to make it easier and faster to access important medications that can benefit human health.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who may benefit from new cancer treatments or other pharmaceutical advancements.
Not a fit: Patients who are not seeking new treatment options or those with conditions not addressed by the new drug compounds may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more efficient development of new medications for various diseases, including cancer.
How similar studies have performed: Other research has shown success in developing similar catalytic processes for drug discovery, indicating a promising approach.
Where this research is happening
Gainesville, United States
- University of Florida — Gainesville, United States (Active)
Researchers
- Principal investigator: Wasa, Masayuki — University of Florida
- Study coordinator: Wasa, Masayuki
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.